278 filings
Page 3 of 14
DEFA14A
exenr1339imvar
3 Feb 21
Additional proxy soliciting materials
5:31pm
8-K
0r651 daoz6id3opj3u
3 Feb 21
Other Events
5:30pm
DEFA14A
iub2c92 x9
3 Feb 21
Additional proxy soliciting materials
5:29pm
DEFA14A
wx0ziyyd7xnh5m
3 Feb 21
Additional proxy soliciting materials
9:05am
8-K
9xvky60sxoeq6zv
3 Feb 21
Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating
9:03am
DFAN14A
03kz 8sc3febpvei
3 Feb 21
Additional proxy materials by non-management
8:43am
8-K
jbe74743vatsa5jn
12 Jan 21
GW Pharmaceuticals Provides Preliminary Fourth Quarter and Full-Year 2020 Net Product Sales Results and 2021 Program Milestones
11:38am
8-K
q9pibs5kho095f6h
3 Nov 20
GW Pharmaceuticals plc Reports Third Quarter 2020 Financial Results
10:42am
8-K
gchgs63
10 Sep 20
GW Pharmaceuticals Announces the Appointment of David Gryska to its Board of Directors
4:31pm
8-K
f74hklx32 aibc
6 Aug 20
GW Pharmaceuticals plc Reports Second Quarter 2020 Financial Results and Operational Progress
5:23pm
S-8
9e93jal8fouu oeu
27 May 20
Registration of securities for employees
5:02pm
8-K
vyk8e9o4emm880ps3t
27 May 20
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
c5c3oy 0zsg55rs60r4
12 May 20
GW Pharmaceuticals plc Reports First Quarter 2020 Financial Results
12:00am
DEFA14A
7kf6xlbftja3 irg
6 May 20
Additional proxy soliciting materials
5:00pm